
Pancreatic Cancer Treatment Shows Promise with Experimental Drug
A groundbreaking development in the treatment of pancreatic cancer has emerged with the analysis of clinical trials conducted by Dr. Monique Yohanan on the drug Rasonque from Revolution Medicines. The trial revealed that patients with stage 4 pancreatic cancer experienced a median survival of 13.2 months, a significant improvement from the 6.7 months survival with […]








